ZA983327B - Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine. - Google Patents

Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine.

Info

Publication number
ZA983327B
ZA983327B ZA9803327A ZA983327A ZA983327B ZA 983327 B ZA983327 B ZA 983327B ZA 9803327 A ZA9803327 A ZA 9803327A ZA 983327 A ZA983327 A ZA 983327A ZA 983327 B ZA983327 B ZA 983327B
Authority
ZA
South Africa
Prior art keywords
aqueous solvent
virus type
herpes virus
solvent based
subunit vaccine
Prior art date
Application number
ZA9803327A
Other languages
English (en)
Inventor
Manuel Campos
Patrick Frenchick
Frederick Clark
Paul Offit
Charlotte Moser
Tully Speaker
Original Assignee
Pfizer
Univ Temple
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Univ Temple, Philadelphia Children Hospital filed Critical Pfizer
Publication of ZA983327B publication Critical patent/ZA983327B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/813—Viral vaccine for bovine species, e.g. cattle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
ZA9803327A 1997-04-23 1998-04-21 Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine. ZA983327B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4417297P 1997-04-23 1997-04-23

Publications (1)

Publication Number Publication Date
ZA983327B true ZA983327B (en) 1999-10-21

Family

ID=21930892

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9803327A ZA983327B (en) 1997-04-23 1998-04-21 Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine.

Country Status (15)

Country Link
US (1) US6270800B1 (zh)
EP (1) EP0873752B1 (zh)
JP (1) JPH10316586A (zh)
CN (1) CN1196931A (zh)
AR (1) AR012009A1 (zh)
AT (1) ATE262324T1 (zh)
AU (1) AU713639B2 (zh)
BR (1) BR9801435A (zh)
CA (1) CA2229430A1 (zh)
DE (1) DE69822542T2 (zh)
DK (1) DK0873752T3 (zh)
ES (1) ES2216242T3 (zh)
NZ (1) NZ330251A (zh)
PT (1) PT873752E (zh)
ZA (1) ZA983327B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855316B1 (en) * 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
ES2368987T3 (es) * 1999-02-05 2011-11-24 Alk-Abelló A/S Sistema de administración a través de las mucosas.
KR20010003853A (ko) * 1999-06-25 2001-01-15 박호군 경구용 백신으로 사용할 수 있는 알긴산염 마이크로스피어 및그 제조방법
US7037681B2 (en) * 2000-02-08 2006-05-02 University Of Hawaii Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
US20030100106A1 (en) * 2000-02-08 2003-05-29 Chang Sandra P. Baculovirus produced Plasmodium falciparum vaccine
JP4370451B2 (ja) * 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
WO2006063030A1 (en) * 2004-12-08 2006-06-15 Speaker Tycho J Microencapsulation product and process
CN104302279A (zh) * 2012-05-10 2015-01-21 聚和国际股份有限公司 用于制备微胶囊的组合物及用其所制得的药物
WO2014193908A1 (en) 2013-05-28 2014-12-04 Capsulent Products containing charged polymer complex microcapsules and method of use
CN107973840A (zh) * 2017-01-13 2018-05-01 浙江海隆生物科技有限公司 CHO细胞表达牛传染性病气管炎病毒gD蛋白及其亚单位疫苗的制备和应用
CN112180089A (zh) * 2020-09-21 2021-01-05 黑龙江八一农垦大学 一种牛疱疹病毒i型抗体阻断elisa检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
US5462734A (en) * 1990-11-02 1995-10-31 Wisconsin Alumni Research Foundation Bovine herpesvirus vaccine and method of using same
ATE235959T1 (de) * 1994-04-15 2003-04-15 Univ Temple Methode zum einkapseln mittels eines wässrigen lösungsmittels und mikrokapseln
US5686113A (en) * 1995-03-21 1997-11-11 Temple University Of The Commonwealth System Of Higher Education Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses

Also Published As

Publication number Publication date
DK0873752T3 (da) 2004-05-10
US6270800B1 (en) 2001-08-07
AU6351198A (en) 1998-11-12
ES2216242T3 (es) 2004-10-16
ATE262324T1 (de) 2004-04-15
PT873752E (pt) 2004-07-30
EP0873752A2 (en) 1998-10-28
AU713639B2 (en) 1999-12-09
AR012009A1 (es) 2000-09-13
JPH10316586A (ja) 1998-12-02
NZ330251A (en) 1998-11-25
EP0873752A3 (en) 2001-02-07
EP0873752B1 (en) 2004-03-24
DE69822542D1 (de) 2004-04-29
DE69822542T2 (de) 2004-08-05
CA2229430A1 (en) 1998-10-23
BR9801435A (pt) 2000-01-11
CN1196931A (zh) 1998-10-28

Similar Documents

Publication Publication Date Title
IL181468A0 (en) E2 subunit vaccine comprising recombinant pestivirus e2 protein
EP0621339A3 (en) Immunogenic human influenza a virus haemagglutinin polypeptides.
HU9800802D0 (en) Influenza vaccine
ZA975889B (en) HIV envelope polypeptides and vaccine.
IL136446A0 (en) Vaccine
AU4653989A (en) Biologically competent, virus inactivated albumin
HUP0000589A3 (en) Aqueous formulations of peptides
HK1030768A1 (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents.
ZA983327B (en) Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine.
AU3328900A (en) Influenza virus hemagglutinin-binding peptides
GB9826069D0 (en) HIV vaccine
HUP9701586A3 (en) Improved inactivated vaccines
EP0366238A3 (en) Influenza vaccinal polypeptides
IL148191A0 (en) Recombinant subunit vaccine
AU7915398A (en) An influenza enveloped dna vaccine
NZ230459A (en) Method of purifying the ha2 subunit of the influenza virus ha protein
AU6127498A (en) Msh-receptor subtype selective cyclic peptides
GB9704977D0 (en) FIV vaccine
GB9702990D0 (en) Virus vaccine
IL136230A0 (en) An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
GB9725241D0 (en) Hiv vaccine
GB9703202D0 (en) HIV vaccine
AU3930895A (en) Viral preparations, immunogens, and vaccines
BR1100968A (pt) Formulação de vacina de subunidade
GB9603322D0 (en) Viral preparations,immunogens and vaccines